112 related articles for article (PubMed ID: 1889849)
1. Inhibition of endopeptidase-24.15 decreases blood pressure in normotensive rats.
Genden EM; Molineaux CJ
Hypertension; 1991 Sep; 18(3):360-5. PubMed ID: 1889849
[TBL] [Abstract][Full Text] [Related]
2. Evidence that enzymatic conversion of N-[1(R,S)-carboxy-3-phenylpropyl]-Ala-Ala-Phe-p-aminobenzoate, a specific inhibitor of endopeptidase 24.15, to N-[1(R,S)-carboxy-3-phenylpropyl]-Ala-Ala is necessary for inhibition of angiotensin converting enzyme.
Cardozo C; Orlowski M
Peptides; 1993; 14(6):1259-62. PubMed ID: 8134308
[TBL] [Abstract][Full Text] [Related]
3. Role of angiotensin converting enzyme in the vascular effects of an endopeptidase 24.15 inhibitor.
Telford SE; Smith AI; Lew RA; Perich RB; Madden AC; Evans RG
Br J Pharmacol; 1995 Mar; 114(6):1185-92. PubMed ID: 7620708
[TBL] [Abstract][Full Text] [Related]
4. Enzymatic inactivation of bradykinin by rat brain neuronal perikarya.
DelBel EA; Padovan AP; Padovan GJ; Sellinger OZ; Martins AR
Cell Mol Neurobiol; 1989 Sep; 9(3):379-400. PubMed ID: 2558804
[TBL] [Abstract][Full Text] [Related]
5. Role of kinins in the renal response to enalaprilat in normotensive and hypertensive rats.
Fitzgibbon WR; Jaffa AA; Mayfield RK; Ploth DW
Hypertension; 1996 Feb; 27(2):235-44. PubMed ID: 8567046
[TBL] [Abstract][Full Text] [Related]
6. Role of bradykinin receptors in the renal effects of inhibition of angiotensin converting enzyme and endopeptidases 24.11 and 24.15 in conscious rabbits.
Tomoda F; Lew RA; Smith AI; Madden AC; Evans RG
Br J Pharmacol; 1996 Sep; 119(2):365-73. PubMed ID: 8886422
[TBL] [Abstract][Full Text] [Related]
7. A novel bradykinin antagonist with improved properties.
Lammek B; Wang YX; Gavras I; Gavras H
J Pharm Pharmacol; 1991 Dec; 43(12):887-8. PubMed ID: 1687595
[TBL] [Abstract][Full Text] [Related]
8. Involvement of endopeptidase 24.15 in the inactivation of bradykinin by rat brain slices.
McDermott JR; Gibson AM; Turner JD
Biochem Biophys Res Commun; 1987 Jul; 146(1):154-8. PubMed ID: 2886123
[TBL] [Abstract][Full Text] [Related]
9. Bradykinin antagonism and prostaglandins in blood pressure regulation.
Mulinari R; Gavras I; Franco R; Gavras H
Hypertension; 1989 Jun; 13(6 Pt 2):960-3. PubMed ID: 2567708
[TBL] [Abstract][Full Text] [Related]
10. Metalloendopeptidases EC 3.4.24.15 and EC 3.4.24.16 and bradykinin B2 receptors do not play important roles in renal wrap hypertension in rabbits.
Norman MU; Lew RA; Smith AI; Denton KM; Evans RG
Clin Exp Pharmacol Physiol; 2001 Oct; 28(10):836-41. PubMed ID: 11553025
[TBL] [Abstract][Full Text] [Related]
11. Effects of Hoe 140, a bradykinin B2-receptor antagonist, on renal function in conscious normotensive rats.
Madeddu P; Anania V; Parpaglia PP; Demontis MP; Varoni MV; Pisanu G; Troffa C; Tonolo G; Glorioso N
Br J Pharmacol; 1992 Jun; 106(2):380-6. PubMed ID: 1327379
[TBL] [Abstract][Full Text] [Related]
12. Endopeptidase 24.15 modulates bradykinin-induced contraction in guinea-pig trachea.
Da Silva A; Dhuy J; Waeldelé F; Bertrand C; Landry Y
Eur J Pharmacol; 1992 Feb; 212(1):97-9. PubMed ID: 1372868
[TBL] [Abstract][Full Text] [Related]
13. Effects of a metalloendopeptidase-24.15. Inhibitor on renal hemodynamics and function in rats.
Yang XP; Saitoh S; Scicli AG; Mascha E; Orlowski M; Carretero OA
Hypertension; 1994 Jan; 23(1 Suppl):I235-9. PubMed ID: 8282366
[TBL] [Abstract][Full Text] [Related]
14. Use of an indwelling catheter for examining cardiovascular responses to pericardial administration of bradykinin in rat.
McDermott DA; Meller ST; Gebhart GF; Gutterman DD
Cardiovasc Res; 1995 Jul; 30(1):39-46. PubMed ID: 7553722
[TBL] [Abstract][Full Text] [Related]
15. Synthetic inhibitors of endopeptidase EC 3.4.24.15: potency and stability in vitro and in vivo.
Lew RA; Tomoda F; Evans RG; Lakat L; Boublik JH; Pipolo LA; Smith AI
Br J Pharmacol; 1996 Jul; 118(5):1269-77. PubMed ID: 8818353
[TBL] [Abstract][Full Text] [Related]
16. Rostral ventrolateral medulla as a site for the central hypertensive action of kinins.
Privitera PJ; Thibodeaux H; Yates P
Hypertension; 1994 Jan; 23(1):52-8. PubMed ID: 7904256
[TBL] [Abstract][Full Text] [Related]
17. Hypertensive effect of a bradykinin antagonist in normotensive rats.
Benetos A; Gavras I; Gavras H
Hypertension; 1986 Nov; 8(11):1089-92. PubMed ID: 3770870
[TBL] [Abstract][Full Text] [Related]
18. A new highly potent antagonist of bradykinin.
Lammek B; Wang YX; Gavras I; Gavras H
Peptides; 1990; 11(5):1041-3. PubMed ID: 2284196
[TBL] [Abstract][Full Text] [Related]
19. Interaction of ANP and bradykinin during endopeptidase 24.11 inhibition: renal effects.
Smits GJ; McGraw DE; Trapani AJ
Am J Physiol; 1990 May; 258(5 Pt 2):F1417-24. PubMed ID: 2140018
[TBL] [Abstract][Full Text] [Related]
20. Chronic kinin receptor blockade attenuates the antihypertensive effect of ramipril.
Bao G; Gohlke P; Qadri F; Unger T
Hypertension; 1992 Jul; 20(1):74-9. PubMed ID: 1319960
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
